BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14742832)

  • 1. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure.
    Sklar GE; Subramaniam M
    Ann Pharmacother; 2004 Mar; 38(3):498-500. PubMed ID: 14742832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a "NAC" to treating acute liver failure in children?
    Leonis MA; Balistreri WF
    Liver Transpl; 2008 Jan; 14(1):7-8. PubMed ID: 18161797
    [No Abstract]   [Full Text] [Related]  

  • 3. N-acetylcysteine in acute hepatic failure (non-paracetamol-induced).
    Ben-Ari Z; Vaknin H; Tur-Kaspa R
    Hepatogastroenterology; 2000; 47(33):786-9. PubMed ID: 10919033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials.
    Hu J; Zhang Q; Ren X; Sun Z; Quan Q
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):594-9. PubMed ID: 25732608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of acetylcysteine for non-acetaminophen-induced acute liver failure.
    Sales I; Dzierba AL; Smithburger PL; Rowe D; Kane-Gill SL
    Ann Hepatol; 2013; 12(1):6-10. PubMed ID: 23293188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure.
    Kortsalioudaki C; Taylor RM; Cheeseman P; Bansal S; Mieli-Vergani G; Dhawan A
    Liver Transpl; 2008 Jan; 14(1):25-30. PubMed ID: 18161828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk of acute hepatic insufficiency in children due to chronic accidental overdose of paracetamol (acetaminophen)].
    Hameleers-Snijders P; Hogeveen M; Smeitink JA; Kramers C; Draaisma JM
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):897-900. PubMed ID: 17500339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of intravenous N-acetylcysteine in dengue haemorrhagic fever with acute liver failure.
    Abeysekera RA; Illangasekera U; Jayalath T; Sandeepana AG; Kularatne SA
    Ceylon Med J; 2012 Dec; 57(4):166-7. PubMed ID: 23292059
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver: Management of non-acetaminophen-induced ALF.
    Riordan SM; Williams R
    Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):75-7. PubMed ID: 20134487
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of hepatic failure despite use of intravenous acetylcysteine after a massive ingestion of acetaminophen and diphenhydramine.
    Schwartz EA; Hayes BD; Sarmiento KF
    Ann Emerg Med; 2009 Sep; 54(3):421-3. PubMed ID: 18986731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study.
    Nabi T; Nabi S; Rafiq N; Shah A
    Saudi J Gastroenterol; 2017; 23(3):169-175. PubMed ID: 28611340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of N-acetylcysteine in the treatment of non-acetaminophen acute liver failure.
    Teriaky A
    Saudi J Gastroenterol; 2017; 23(3):131-132. PubMed ID: 28611335
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical management of acute liver failure in the Intensive Care Unit.
    Trotter JF
    Curr Opin Crit Care; 2009 Apr; 15(2):163-7. PubMed ID: 19578326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [N-Acetylcysteine: new possibilities to use an old substance].
    Ahola T; Lapatto R
    Duodecim; 1999; 115(4):375-9. PubMed ID: 11830885
    [No Abstract]   [Full Text] [Related]  

  • 16. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
    Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
    Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL
    Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.
    Squires RH; Dhawan A; Alonso E; Narkewicz MR; Shneider BL; Rodriguez-Baez N; Olio DD; Karpen S; Bucuvalas J; Lobritto S; Rand E; Rosenthal P; Horslen S; Ng V; Subbarao G; Kerkar N; Rudnick D; Lopez MJ; Schwarz K; Romero R; Elisofon S; Doo E; Robuck PR; Lawlor S; Belle SH;
    Hepatology; 2013 Apr; 57(4):1542-9. PubMed ID: 22886633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON).
    Komisarof JA; Gilkey GM; Peters DM; Koudelka CW; Meyer MM; Smith SM
    Crit Care Med; 2007 Feb; 35(2):435-41. PubMed ID: 17205018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critically ill liver patient: fulminant hepatic failure.
    McGuire BM
    Semin Gastrointest Dis; 2003 Jan; 14(1):39-42. PubMed ID: 12610854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.